Needham & Company Upgrades Wright Medical (WMGI) to Buy

Go back to Needham & Company Upgrades Wright Medical (WMGI) to Buy

BMO Capital Upgrades Wright Medical (WMGI) to Outperform

August 28, 2018 9:15 AM EDT

BMO Capital analyst Joanne Wuensch upgraded Wright Medical (NASDAQ: WMGI) from Market Perform to Outperform with a price target of $31.00 (from $28.00).

For an analyst ratings summary and ratings history on Wright Medical click here. For more ratings news on Wright Medical click here.

Shares of Wright Medical closed at $26.05 yesterday.

... More

Wright Medical Group (WMGI) Prices 18.25M Share Common Offering at $24.60/Sh

August 28, 2018 5:42 AM EDT

Wright Medical Group N.V. (NASDAQ: WMGI) today announced the pricing of its previously announced registered underwritten public offering of 18,248,932 of its ordinary shares at an initial price to the public of $24.60 per share. The net proceeds to Wright from the offering, after deducting the... More

Wright Medical (WMGI) PT Raised to $31 at Jefferies

August 27, 2018 4:09 PM EDT

Jefferies analyst Raj Denhoy raised the price target on Wright Medical (NASDAQ: WMGI) to $31.00 (from $30.00) while maintaining a Buy rating.

... More

Wright Medical Group (WMGI) Reports Agreement to Acquire Cartiva Inc. for $435M in Cash

August 27, 2018 6:01 AM EDT

Wright Medical Group N.V. (NASDAQ: WMGI) today announced it has entered into a definitive agreement to acquire Cartiva, Inc., a private orthopaedic medical device company focused on treatment of osteoarthritis of the great toe. The transaction will add a differentiated PMA-approved technology for a high-volume foot and ankle procedure and further accelerates growth opportunities in Wrights global Extremities business.

Under the terms of the agreement with Cartiva, Wright will acquire 100% of Cartivas outstanding equity on a fully diluted basis for a total price of $435 million in cash.

Cartivas lead... More